Inogen, Inc.INGNNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank69
3Y CAGR-30.7%
5Y CAGR+16.2%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-30.7%/yr
vs -26.3%/yr prior
5Y CAGR
+16.2%/yr
Recent deceleration
Acceleration
-4.4pp
Decelerating
Percentile
P69
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 20259.83%
Q3 2025-7.08%
Q2 202529.13%
Q1 2025-31.60%
Q4 202467.65%
Q3 2024-37.36%
Q2 2024-14.62%
Q1 2024-2.03%
Q4 202349.57%
Q3 20234.57%
Q2 2023-19.67%
Q1 2023-9.94%
Q4 202229.54%
Q3 2022-24.46%
Q2 202213.05%
Q1 202214.52%
Q4 202124.77%
Q3 2021-8.95%
Q2 20212.69%
Q1 20219.28%
Q4 20204.64%
Q3 20206.72%
Q2 2020-8.74%
Q1 2020-0.63%
Q4 201937.63%
Q3 201979.56%
Q2 2019-12.04%
Q1 2019-4.19%
Q4 2018-16.89%
Q3 201818.08%
Q2 201825.35%
Q1 20183.43%
Q4 2017-0.44%
Q3 20179.13%
Q2 2017-3.74%
Q1 20177.65%
Q4 2016-9.93%
Q3 2016-2.10%
Q2 201618.07%
Q1 2016-4.73%